Literature DB >> 17180360

Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients.

Vikas R Dharnidharka, Stanton K Wesson, Robert S Fennell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17180360     DOI： 10.1007/s00467-006-0384-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients.

Authors:  Maria Paz Marco; Salomé Muray; Angels Betriu; Lourdes Craver; Montserrat Belart; Elvira Fernández
Journal:  Nephron       Date:  2002-10       Impact factor: 2.847

2.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

3.  Nephrogenic fibrosing dermopathy in pediatric patients.

Authors:  Sima M Jain; Stanton Wesson; Ashraf Hassanein; Erica Canova; Miranda Hoy; Robert S Fennell; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2004-02-10       Impact factor: 3.714
  3 in total
  10 in total

Review 1.  Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children.

Authors:  Musturay Karcaaltincaba; Berna Oguz; Mithat Haliloglu
Journal:  Pediatr Radiol       Date:  2009-06

2.  Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.

Authors:  Beatrice Nardone; Elise Saddleton; Anne E Laumann; Beatrice J Edwards; Dennis W Raisch; June M McKoy; Steven M Belknap; Christian Bull; Anand Haryani; Shawn E Cowper; Ali K Abu-Alfa; Frank H Miller; Victoria Godinez-Puig; Vikas R Dharnidharka; Dennis P West
Journal:  Pediatr Radiol       Date:  2013-09-21

3.  MR urography in children. Part 1: how we do the F0 technique.

Authors:  Pierre-Hugues Vivier; Michael Dolores; Melissa Taylor; Frederic Elbaz; Agnes Liard; Jean-Nicolas Dacher
Journal:  Pediatr Radiol       Date:  2010-02-25

4.  Nephrogenic fibrosing dermatopathy, cardiac calcification and pulmonary hypertension in an adolescent on chronic hemodialysis.

Authors:  J Sharma; A Mongia; M Schoenaman; S Chang; A D'Angelo; M Rao
Journal:  Indian J Nephrol       Date:  2008-04

Review 5.  Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.

Authors:  Jeffrey G Penfield
Journal:  Pediatr Nephrol       Date:  2008-06-10       Impact factor: 3.714

Review 6.  Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

Review 7.  Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature.

Authors:  Jeffrey P Weigle; Dale R Broome
Journal:  Skeletal Radiol       Date:  2008-03-07       Impact factor: 2.199

Review 8.  Gadolinium and nephrogenic systemic fibrosis: time to tighten practice.

Authors:  Iosif A Mendichovszky; Stephen D Marks; Clare M Simcock; Oystein E Olsen
Journal:  Pediatr Radiol       Date:  2007-10-18

Review 9.  Good MRI images: to Gad or not to Gad?

Authors:  Henning Steen; Vedat Schwenger
Journal:  Pediatr Nephrol       Date:  2007-05-22       Impact factor: 3.714

Review 10.  Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review.

Authors:  Sandra Lange; Wioletta Mędrzycka-Dąbrowska; Katarzyna Zorena; Sebastian Dąbrowski; Daniel Ślęzak; Anna Malecka-Dubiela; Przemysław Rutkowski
Journal:  Int J Environ Res Public Health       Date:  2021-03-15       Impact factor: 3.390
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.